Supplement Facts 1 Capsule
Because retatrutide does not yet have an approved label, it should not be described as covered for type 2 diabetes, obesity, chronic weight management, obstructive sleep apnea, or any other condition in routine care
March 2, 2026: Gastrointestinal Lawsuits Involving Trulicity, Other GLP-1s Increase in March Eli Lilly and one other drug company are facing 3,363 lawsuits in a consolidated MDL, in which plaintiffs accuse the companies of failing to warn patients about the gastrointestinal risks of taking Trulicity and other GLP-1s
Symptoms may include: severe or ongoing stomach pain a swollen, hard, or tender belly vomiting that will not stop being unable to pass stool or gas no bowel movement for several days What to do Contact your healthcare provider if digestive symptoms are severe or will not go away
Wang W, Green M, Choi JE, Gijn M, Kennedy PD, Johnson JK, et al